Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for drug discovery and development ...

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

Today, adoption of digital health faces some of the same barriers — scepticism, budget limitations, high expectations, and a ...

Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Sri Aurobindo Institute of Pharmacy (SAIP), Indore, successfully hosted a National Conference on “Pharma Innovations: Cross-Disciplinary Approaches in Drug Development and Healthcare” on Friday, ...

This article explores how digital maturity in process design and parameter management can drive significant time and cost savings, streamline tech transfers and ultimately accelerate patient access to ...

Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...